These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2982025)

  • 21. Amino-terminal mutation of the vesicular stomatitis virus glycoprotein does not affect its fusion activity.
    Woodgett C; Rose JK
    J Virol; 1986 Aug; 59(2):486-9. PubMed ID: 3016308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of vesicular stomatitis virus glycoprotein expression by chloroquine.
    Dille BJ; Johnson TC
    J Gen Virol; 1982 Sep; 62 (Pt 1)():91-103. PubMed ID: 6290597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell killing by viruses. V. Transcribing defective interfering particles of vesicular stomatitis virus function as cell-killing particles.
    Marcus PI; Sekellick MJ; Johnson LD; Lazzarini RA
    Virology; 1977 Oct; 82(1):242-6. PubMed ID: 197702
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of intracellular vesicular stomatitis virus mRNA concentration on the inhibition of host cell protein synthesis.
    Schnitzlein WM; O'Banion MK; Poirot MK; Reichmann ME
    J Virol; 1983 Jan; 45(1):206-14. PubMed ID: 6296431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninfectious vesicular stomatitis virus particles deficient in the viral nucleocapsid.
    Schnitzer TJ; Lodish HF
    J Virol; 1979 Feb; 29(2):443-7. PubMed ID: 219239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of polykaryocyte induction by vesicular stomatitis virus in rat XC cells.
    Chany-Fournier F; Chany C; Lafay F
    J Gen Virol; 1977 Feb; 34(2):305-14. PubMed ID: 190346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
    Ferran MC; Lucas-Lenard JM
    J Virol; 1997 Jan; 71(1):371-7. PubMed ID: 8985359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA.
    Grinnell BW; Wagner RR
    J Virol; 1983 Oct; 48(1):88-101. PubMed ID: 6193289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation.
    Grdzelishvili VZ; Smallwood S; Tower D; Hall RL; Hunt DM; Moyer SA
    J Virol; 2005 Jun; 79(12):7327-37. PubMed ID: 15919887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viruses isolated from cells persistently infected with vesicular stomatitis virus show altered interactions with defective interfering particles.
    Horodyski FM; Holland JJ
    J Virol; 1980 Nov; 36(2):627-31. PubMed ID: 6253684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultraviolet-irradiated vesicular stomatitis virus and defective-interfering particles are similar non-specific inhibitors of virus infection.
    Miller DK; Lenard J
    J Gen Virol; 1982 Jun; 60(Pt 2):327-33. PubMed ID: 6286855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH.
    Florkiewicz RZ; Rose JK
    Science; 1984 Aug; 225(4663):721-3. PubMed ID: 6087454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and physiological properties of temperature-sensitive mutants of Cocal virus.
    Pringle CR; Wunner WH
    J Virol; 1973 Oct; 12(4):677-83. PubMed ID: 4359947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstruction experiments demonstrating selective effects of defective interfering particles on mixed populations of vesicular stomatitis virus.
    Horodyski FM; Holland JJ
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():819-23. PubMed ID: 6323624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity.
    Hoffmann M; Wu YJ; Gerber M; Berger-Rentsch M; Heimrich B; Schwemmle M; Zimmer G
    J Gen Virol; 2010 Nov; 91(Pt 11):2782-93. PubMed ID: 20631091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA synthesis in temperature-sensitive mutants of vesicular stomatitis virus.
    Unger JT; Reichmann ME
    J Virol; 1973 Sep; 12(3):570-8. PubMed ID: 4355855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of glycosylation in transport of vesicular stomatitis virus envelope glycoprotein. A new class of mutant defective in glycosylation and transport of G protein.
    Kotwal GJ; Buller ML; Wunner WH; Pringle CR; Ghosh HP
    J Biol Chem; 1986 Jul; 261(19):8936-43. PubMed ID: 3013867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.
    Black BL; Rhodes RB; McKenzie M; Lyles DS
    J Virol; 1993 Aug; 67(8):4814-21. PubMed ID: 8392615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Envelope proteins of vesicular stomatitis virus: effect of temperature-sensitive mutations in complementation groups III and V.
    Lafay F
    J Virol; 1974 Nov; 14(5):1220-8. PubMed ID: 4372395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. Evidence for an intracellular, G protein-requiring step.
    Miller DK; Lenard J
    J Cell Biol; 1980 Feb; 84(2):430-7. PubMed ID: 6247355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.